Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8551485 | Regulatory Toxicology and Pharmacology | 2018 | 23 Pages |
Abstract
Before therapy was found significantly higher levels of CAT activity and MDA compared to the patients after therapy and control group (p < 0.05). Moreover, levels of Asc* radicals in patients before therapy were significantly lower than those measured in controls and patients undergoing therapy (p < 0.05). Our finding, the combined therapy applied to vitiligo patients provoked an increase in the Asc* levels and a decrease in MDA products and also initial repigmentation in the vitiligo spots, made us believe that a combined antioxidant therapy, enriched with vitamin C could lead to improvement of the oxidant-antioxidant balance in vitiligo patients treated with UVB 311 phototherapy.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
A. Zheleva, G. Nikolova, Y. Karamalakova, E. Hristakieva, R. Lavcheva, V. Gadjeva,